Skip to main content
S

SAVA

SAVA develops a minimally invasive biosensing platform that continuously monitors multiple biomolecules just below the skin, providing real-time health data directly to users' smartphones. This technology addresses the need for accessible and affordable health monitoring, enabling proactive management of chronic conditions and overall well-being.

London, United KingdomFounded 2019802K+ followers
Updated 20 months ago

Funding

$11.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

EV
Funding rounds are not available yet.

Founders

Product

Problem

Current methods for monitoring health biomarkers often require invasive procedures or episodic lab tests, limiting the ability to track real-time changes and proactively manage health conditions. Existing wearable sensors typically measure surface-level data, lacking the ability to directly monitor key biomolecules beneath the skin.

Solution

SAVA is developing a minimally invasive biosensing platform that continuously monitors multiple biomolecules just below the skin, providing real-time health data directly to users' smartphones. The sensor technology gathers data from the interstitial fluid, offering insights into glucose, lactate, ketones, sodium, histamine, urea, alcohol, and cortisol levels. This continuous monitoring approach aims to enable proactive management of chronic conditions, improve athletic performance, and provide a more comprehensive understanding of overall well-being. The data is streamed to a connected platform, providing users with effortless access to health insights anywhere, anytime.

Target Audience

The primary target audience includes individuals with diabetes, athletes seeking to optimize performance, and health-conscious individuals interested in proactive health management.

Features

  • Minimally invasive sensor technology for continuous, real-time monitoring of biomolecules in interstitial fluid
  • Multi-molecule detection capabilities, including glucose, lactate, ketones, sodium, histamine, urea, alcohol, and cortisol
  • Wireless data transmission to a smartphone app for convenient access to health insights
  • Low-cost design engineered for high-volume manufacturing and affordability
  • Potential applications for diabetes management, athletic performance tracking, and general wellness monitoring
This profile is AI-generated and may contain inaccuracies.